Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 745-748

  Mukai, Masaya ^a   Sato, Shinkichi ^a   Kimura, Tomomi ^a   Komatsu, Nobukazu ^a   Ninomiya, Hiromi ^a   Nakasaki, Hisao ^a   Ogoshi, Kyouji ^b   Makuuchi, Hiroyasu ^b  

^a TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Breast cancer; High risk group; Isolated tumor cells; Lymph node metastasis; Metastasis; Micrometastasis; Occult neoplastic cells; Recurrence

Indexed keywords

ARTICLE; BLOOD; BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; OCCULT BLOOD; PATHOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR EMBOLISM; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM CIRCULATING CELLS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 16644394119     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.745     Document Type: Article

References (32)

1. Omejc M, Juvan R, Jelenc F and Repse S: Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg 86: 14-19, 2001. (Pubitemid 33594597)
2. Japanese Society for Cancer of the Colon and Rectum: Multi-institutional registry of large bowel cancer in Japan. Vol. 23. Cases treated in 1994. Tokyo, 2002.
3. Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Brochhagen H-G, Schneider PM and Hölscher AH: Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123: 463-467, 2003. (Pubitemid 36269431)
4. Hasebe T, Sasaki S, Imoto S and Ochiai A: Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast. Cancer Sci 94: 181-187, 2003. (Pubitemid 36575878)
5. Goldhirsch A, Glick JH, Gelber RD and Senn H-J: Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90: 1601-1608, 1998. (Pubitemid 28523434)
6. National Institutes of Health Consensus Development Panel: National institutes of health consensus development conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93: 979-989, 2001.
7. Goldhirsch A, Glick JH, Gelber RD, Coates AS and Senn H-J: Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19: 3817-3827, 2001. (Pubitemid 32880060)
8. Abrams JS: Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer 8: 298-304, 2001.
9. Mukai M, Tajima T, Saito Y, Ito I, Nakasaki H, Sato S and Makuuchi H: Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Oncol Rep 10: 927-934, 2003.
10. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' B colorectal cancer. Ann Cancer Res Ther 11: 201-214, 2003. (Pubitemid 39334896)
11. Mukai M, Tajima T, Nakasaki H, Sato S, Ogoshi K and Makuuchi H: Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' C colorectal cancer. Ann Cancer Res Ther 11: 215-229, 2003. (Pubitemid 39341153)
12. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer. Oncol Rep 10: 1177-1181, 2003.
13. Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H and Makuuchi H: Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer. Oncol Rep 10: 1165-1169, 2003.
14. Mukai M, Sato S, Nishida T, Komatsu N, Shiba K, Nakasaki H and Makuuchi H: Selection criteria for high-risk and low-risk groups of recurrence and metastasis in patients with primary colorectal cancer. Oncol Rep 10: 1753-1758, 2003.
15. Mukai M, Sato S, Nakasaki H, Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H and Makuuchi H: Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal and gastric cancer. Oncol Rep 11: 81-84, 2004.
16. Mukai M, Sato S, Komatsu N, Kimura T, Ninomiya H, Kawada M, Nakasaki H, Ogoshi K and Makuuchi H: Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer patients with lymph node metastasis. Oncol Rep 12: 63-66, 2004.
17. Mukai M, Sato S, Kimura T, Komatsu N, Ninomiya H, Nakasaki H, Ogoshi K and Makuuchi H: Criteria for predicting recurrence and metastasis in stage I and II gastric cancer without lymph node metastasis. Oncol Rep 12: 59-62, 2004.
18. Japanese Classification of Gastric Carcinoma: Japanese Research Society for Gastric Cancer (1st English edition). Kanehara & Co., Ltd., Tokyo, 1995.
19. General Rules for Clinical and Pathological Recording of Breast Cancer: Japanese Breast Cancer Society (13th edition). Kanehara&Co., Ltd., Tokyo, 1998.
20. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus: Japanese Society for Cancer of the Colon and Rectum (6th edition). Kanehara&Co., Ltd., Tokyo, 1998.
21. Nakane PK and Pierce GB: Enzyme-labeled antibodies: preparation and application for localization of antigens. J Histochem Cytochem 14: 929-931, 1966.
22. Nakane PK and Pierce GB: Enzyme-labeled antibody for the light and electron microscopic localization of tissue antigens. J Cell Biol 33: 307-318, 1967.
23. Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka Medical Center, for Cancer and Cardiovascular Disease: Annual report of Osaka Cancer registry no. 65 - cancer incidence and medical care in Osaka in 1999 and the survival in 1995 - OPDPHW, 2002.
24. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CRM, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmiiller G and Schlimok G: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342: 525-533, 2000. (Pubitemid 30117892)
25. Müller P and Schlimok G: Bone marrow 'micrometastasis' of epithelial tumors: detection and clinical relevance. J Cancer Res Clin Oncol 126: 607-618, 2000.
26. Ikeda N, Miyoshi Y, Motomura K, Inaji H, Koyama H and Noguchi S: Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA. Jpn J Cancer Res 91: 918-924, 2000.
27. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, MacDonald JS, Catalano PJ and Haller DG: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919, 2003. (Pubitemid 46621841)
28. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D and Sargent D: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93: 583-596, 2001. (Pubitemid 32409626)
29. TNM classification of malignant tumours: 6th edition. John Wiley & Sons, Inc., Publication, New York, 2002.
30. Swedish Breast Cancer Cooperative Group: Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst 88: 1543-1549, 1996.
31. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451-1467, 1998.
32. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N and Other National Surgical Adjuvant Breast and Bowel Project Investigators: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 90: 1371-1388, 1998. Organization